The short version of Anti-doping testing fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-08 and is reviewed periodically as new material appears.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Axial oscillations of ion rings are detected by their image current induced on the outer electrode which is split into two symmetrical pick-up sensors connected to a differential amplifier. By processing data in a manner similar to that used in Fourier-transform ion cyclotron resonance mass spectrometry (FTICR-MS), the trap can be used as a mass analyzer. Like in FTICR-MS, all the ions are detected simultaneously over some given period of time and resolution can be improved by increasing the strength of the field or by increasing the detection period. The Orbitrap differs from FTICR-MS by the absence of a magnetic field and hence has a significantly slower decrease of resolving power with increasing m/z.
The Mazda MX-5 was developed around the same time in the US, but had tried to imitate the 1960s Lotus Elan. How Naoki Sakai originated the Italian-heritage Nissan Figaro in the early 1990s - the car, made for Japanese women in a limited production, became so popular that it had to be sold by lottery. How the Mazda research centre at Kanagawa-ku, Yokohama was making intelligent cars.
A. Ajayaghosh, born on 30 July 1962 in Kollam in the south Indian state of Kerala, graduated in science from the University of Kerala and completed his master's degree from Calicut university in 1984. Subsequently, working under the guidance of Prof. V. N. Rajasekharan Pillai, he secured a Ph.D. from University of Calicut in 1989; his thesis was on Solid-Phase Peptide Synthesis. His career started in 1988 at the Regional Research Laboratory, presently the National Institute for Interdisciplinary Science and Technology (NIIST), of the Council of Scientific and Industrial Research, as a Scientist and held various positions before promoting to an Outstanding Scientist (Scientist-H) and the head of the Photosciences and Photonics Group of NIIST. Subsequently he became the head of the Chemical Sciences and Technology group He was the director of the Institute from 2015 and held the additional responsibility as the Dean of Chemical Sciences, Academy of Scientific and Innovative Research (AcSIR) New Delhi. In between, he was as an Alexander von Humboldt Fellow at the Max Planck Institute for Strahlen Chemie, Germany during 1994–96. He served as an adjunct professor of Material Science Programme at the Indian Institute of Technology, Kanpur. Presently, he is a J. C. Bose National Fellow at CSIR-NIIST and an adjunct professor at IISER Thiruvananthapuram. Ajayaghosh is married to Ambili, and together they have two children, one of whom is Anantharaman Ajay, known for his roles in the 2023 movie "Romancham", Gaganachari, and the YouTube channel "Appooppan and the Boys","Nissaram".
Sources: en.wikipedia.org
The Federal Constitution and the Law of Guidelines and Bases of National Education determine that the union, the states, the Federal District and the municipalities must manage and organize their respective education systems. Each of these public educational systems is responsible for its own maintenance, which manages funds as well as the mechanisms and funding sources. The constitution reserves 25% of the state budget and 18% of federal taxes and municipal taxes for education. According to the IBGE, the literacy rate was 93.4% in 2019, meaning that 11.3 million (6.6% of population) people are still illiterate in the country, with some states such as Rio de Janeiro and Santa Catarina reaching around 97% of literacy rate; functional illiteracy has reached 21.6% of the population. Illiteracy is higher in the Northeast, where 13.87% of the population is illiterate, while the South, has 3.3% illiteracy. Brazil's private institutions tend to be more exclusive and offer better quality education, so many high-income families send their children there. The result is a segregated educational system that reflects extreme income disparities and reinforces social inequality. However, efforts to change this are making impacts. The University of São Paulo is often considered the best in Brazil and Latin America. Of the top 20 Latin American universities, eight are Brazilian; most are public. Attending an institution of higher education is required by Law of Guidelines and Bases of Education. Kindergarten, elementary and medium education are required of all students.
=== Home environment === Poverty, especially in children less than 2 years old, food insecurity and adverse childhood experiences all increase the risk of childhood obesity. Children's food choices are influenced by family meals. In children and young adults aged 11–21, those who had more meals with their family also had greater intake of vegetables, fruits and dairy. The results of a survey in the UK suggest that children raised by their grandparents are more likely to be obese as adults than those raised by their parents. An American study released in 2011 found the more mothers work the more children are more likely to be overweight or obese.
==== Reoxygenation of intolerant animals ==== While it is unclear how reoxygenation affects intolerant ectotherms at the mitochondrial level, there is some research showing how some of them respond. In the hypoxia-sensitive shovelnose ray (Aptychotrema rostrata), it is shown that ROS production is lower upon reoxygenation compared to rays only exposed to normoxia (normal oxygen levels). This differs from the hypoxia-sensitive endotherm, which would see an increase in ROS production. However, the ray's levels were still higher than the more hypoxia-tolerant Epaulette shark (Hemiscyllum ocellatum), which potentially sees hypoxia due to the bouts of low tides that can be seen in reef platforms. Subtidal scallops will see both a decrease in maximal respiration and a depolarization of the membrane during reoxygenation.
Despite the fact that the period of the wars of independence itself was marked by a rapid expansion of representative government, for several of the new nations the nineteenth century was marked by militarism because of the lack of well-defined political and national institutions. The armies and officers that came into existence during the process of independence wanted to ensure that they got their rewards once the struggle was over. Many of these armies did not fully disband once the wars were over and they proved to be one of the stabler institutions in the first decades of national existence. These armies and their leaders effectively influenced the course of political development. Out of this new tradition came the caudillos, strongmen who amassed formal and informal economic, military and political power in themselves.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.